Related Experiment Videos
[Dermatologic manifestations of tuberous sclerosis in children. A study of 6 cases]
Insights
Tuberous sclerosis skin manifestations change with age, starting with hypopigmented maculae in infancy. Facial angiofibromas and fibromas appear later, highlighting age-dependent symptom progression in this genetic disorder.
Area of Science:
- Dermatology
- Genetics
- Pediatrics
Background:
- Tuberous sclerosis is a genetic disorder with high prevalence of skin manifestations.
- Cutaneous findings are often the earliest clinical markers of tuberous sclerosis.
- Understanding the age-dependent progression of skin lesions is crucial for early diagnosis.
Observation:
- This study analyzed 6 pediatric cases of tuberous sclerosis.
- Skin manifestations were documented in relation to patient age.
- Clinical evaluation of first-degree relatives was performed.
Findings:
- Hypopigmented maculae were typically present at birth and often the sole sign in early childhood.
- Facial angiofibromas emerged later, followed by "orange-peel" patches and periungual fibromas.
- The study supports a high spontaneous mutation rate in tuberous sclerosis, as no affected relatives were found.
Implications:
- The age-specific pattern of skin lesions aids in early tuberous sclerosis diagnosis in children.
- Recognizing the sequence of cutaneous findings can improve clinical monitoring.
- Further research into mutation rates and genetic counseling is warranted.
Abstract:
Typical cutaneous findings in tuberous sclerosis are present in over 90% of cases and represent one of the earliest markers of the syndrome. Our study, based on 6 pediatric cases, underlines how the skin manifestations vary with the patient's age. Hypopigmented maculae were usually present at birth and remained often the only clinical sign during the first few years of age. Angiofibromas on the face appeared later and were followed by orange-peel patches and then by periungual fibromas. The high spontaneous new mutation rate of tuberous sclerosis seems to be confirmed by our study in which clinical evaluation of first-degree relatives of all patients was negative.